Business Context and Reporting Period
Envue Medical, Inc. (Nasdaq: FEED) filed a Current Report on Form 8-K on August 28, 2026. The filing announces a corporate action regarding its capital structure, specifically a reverse stock split approved by the Board of Directors and stockholders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the mechanics of the reverse stock split.
- Pre-Split Outstanding Shares: 11,084,616 (as of August 28, 2026)
- Post-Split Outstanding Shares: Approximately 923,718
- Reverse Split Ratio: 12-for-1
- Effective Date: September 1, 2026
- New CUSIP Number: 63008J 876
Material Changes
The primary material change is the reduction in the number of outstanding shares of common stock by a factor of twelve. The filing states that the reverse split will not affect the stated par value of the common stock, the number of authorized shares, or the number of authorized shares of preferred stock. Shareholders' percentage ownership and proportional voting power will remain virtually unchanged, subject to minor adjustments due to the rounding of fractional shares.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future outlook, or specific risk factors beyond the standard mechanics of the split. Key operational details regarding the split include:
- Fractional Shares: No fractional shares will be issued. Shareholders with holdings not evenly divisible by 12 will have their fractional interest rounded up to the nearest whole share.
- Adjustments to Securities: All outstanding options, convertible securities, restricted stock, and warrants will be adjusted. The number of shares underlying these instruments will be divided by 12, and the exercise or conversion price will be multiplied by 12.
- Trading: The stock will continue to trade under the symbol "FEED" on the Nasdaq Capital Market.
Investor Verification Checklist
- Verify the new CUSIP number (63008J 876) for trading purposes effective September 1, 2026.
- Confirm the exact number of post-split shares held, noting that fractional shares are rounded up rather than paid in cash.
- Review the adjusted exercise prices and share counts for any held options, warrants, or restricted stock units.
- Monitor the stock price performance immediately following the effective date to assess market reaction to the capital structure change.